Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

1. Azzouzi, A.-R.
2. Vincendeau, S.
3. Barret, E.
4. Cicco, A.
5. Kleinclauss, F.
6. van der Poel, H.G.
7. Stief, C.G.
8. Rassweiler, J.
9. Salomon, G.
10. Solsona, E.
11. Alcaraz, A.
12. Tammela, T.T.
13. Rosario, D.J.
14. Gomez-Veiga, F.
15. Ahlgren, G.
16. Benzaghou, F.
17. Gaillac, B.
18. Amzal, B.
19. Debruyne, F.M.J.
20. Fromont, G.
21. Gratzke, C.
22. Emberton, M.